Operation Warp Speed therapeutic focus is on products that can be deployed this year

Operation Warp Speed, the U.S. initiative to accelerate COVID-19 countermeasures, has set short-term deadlines for both vaccines and therapies that determine the technologies and products it will support. The initiative’s priorities are important because it is investing billions of dollars, coordinating work across government, and making decisions about the allocation of resources that affect the ability to develop products that are not being supported by Warp Speed.

For therapies, the program is only considering candidates that could be authorized or approved, and produced at scale, this year. ...